XORTX Therapeutics XRTX
NASDAQ XRTX
$0.91 -0.08 (-7.89%)
As of: Oct 21, 2026 · 12:35 PM EDT

XORTX Therapeutics (XRTX) Capital Expenditures (2022 - 2023)

Updated

XORTX Therapeutics (XRTX) reported Capital Expenditures of -$1.00 for the quarter ended Dec 31, 2023, compared with -$4,580 a year earlier.

Analysis

XORTX Therapeutics (XRTX) Capital Expenditures (2022 - 2023) Analysis & Trends

For the year ended Dec 31, 2023, XORTX Therapeutics posted Capital Expenditures of -$4,311.

  • By year, Capital Expenditures came in at -$19,696 in the year ended Dec 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,133.08 Bn 1,101.67 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 616.40 Bn 534.93 Bn 17.26 Bn 1.32 Bn
3 AbbVie 501.19 Bn 474.31 Bn 12.70 Bn 322.00 Mn
4 Merck 367.18 Bn 321.56 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 297.99 Bn 261.98 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 261.67 Bn 235.36 Bn 12.86 Bn 1.86 Bn
7 Amgen 235.57 Bn 190.97 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 190.62 Bn 164.82 Bn 6.22 Bn 140.00 Mn
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn 533.00 Mn
10 XORTX Therapeutics 863,692.13 -2.44 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 8,621.00
Jun 30, 2023 -1,637.00
Mar 31, 2023 -2,673.00
Dec 31, 2022 33,402.85
Sep 30, 2022 -444.71
API Access

XORTX Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=XRTX&period=max&api_key=YOUR_API_KEY